Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from <scp>VERTIS CV</scp>Vikas S. Sridhar, David Z.I. Cherney, Margaret Noyes Essex et al.|Diabetes Obesity and Metabolism|2024Cited by 8